Merck Introduces Fertility Benefit Programme

4th April 2024

Posted In: Be In The Frame

Merck, a leading science and technology company, recently announced the introduction of a Fertility Benefit Programme in Ireland. Merck’s Fertility Benefit was first introduced in nine markets in October of 2023, and plans were announced to offer it globally in 2024. This expansion signifies the next step in this journey, as Merck now offers a Fertility Benefit in 20 markets and continues to work at growing this offering across the globe.

“The caring spirit of Merck truly comes to life when we support our employees through their most important personal moments,” said Belén Garijo, Executive Chair and CEO, Merck. “The expansion of our Fertility Benefit Programme demonstrates this strong commitment to helping those colleagues who want to build a family. We are pioneers in the fertility space and we are thrilled to provide this opportunity to a growing number of Merck families.”

“Across the globe, one in six people will face infertility. As a long-standing leader in fertility, we, at Merck, understand the financial and emotional toll this journey can have on individuals and families.

We are so pleased that the Fertility Benefit Programme has launched in Ireland, allowing us to support our people as they strive to realise their dream of parenthood,” said Mark Dunphy, Site Director and Head of Cork Operations, Merck, Carrigtwohill. 

The Fertility Benefit is available to eligible employees and their partners, regardless of marital status and sexual orientation. A breadth of services will be covered, such as fertility tests, in vitro fertilisation treatments, and hormonal treatments.In line with Merck’s efforts to encourage well-being and create an environment where all feel they belong, the company also offers a robust suite of informational resources related to fertility, and has created a dedicated space for a peer support network.

Merck has been making valued contributions to the fertility field for several decades. The company has grown to be the global market leader in therapies for fertility treatment. An estimated five million babies have been born with the help of Merck products. This represents around half of all babies born through medically assisted reproduction since the birth of the first baby conceived through in vitro fertilisation in 1978.